Craig-Hallum analyst William Bonello maintained a Buy rating on GeneDx Holdings (WGS – Research Report) today. The company’s shares closed ...

GeneDx (WGS) Holdings eported preliminary financial results for the fourth quarter and full year of 2024. “2024 was a transformative year for GeneDx, as we achieved our profitability milestone ...

STAMFORD, Conn. - GeneDx (NASDAQ:WGS), known for its genomic insights to improve health outcomes, has announced Bryan Dechairo as the company's new Chief Operating Officer. Dechairo's immediate ...